Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2011 | 1 |
2024 | 1 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Full kinetic modeling analysis of [18F]fluorocholine Positron Emission Tomography (PET) at initial diagnosis of high-grade glioma.
Neuroimage Clin. 2024 May 6;42:103616. doi: 10.1016/j.nicl.2024.103616. Online ahead of print.
Neuroimage Clin. 2024.
PMID: 38763039
Free PMC article.
We assessed the correlation between the kinetic parameters and the conventional static PET metrics (SUV(max), SUV(mean) and tumor-to-background ratio TBR). We explored the association between the [(18)F]F-CHO-PET quantitative parameters and relevant molecular biomarkers in …
We assessed the correlation between the kinetic parameters and the conventional static PET metrics (SUV(max), SUV(mean) and tumor-to- …
A phase I study of MN-029 (denibulin), a novel vascular-disrupting agent, in patients with advanced solid tumors.
Ricart AD, Ashton EA, Cooney MM, Sarantopoulos J, Brell JM, Feldman MA, Ruby KE, Matsuda K, Munsey MS, Medina G, Zambito A, Tolcher AW, Remick SC.
Ricart AD, et al.
Cancer Chemother Pharmacol. 2011 Oct;68(4):959-70. doi: 10.1007/s00280-011-1565-4. Epub 2011 Feb 9.
Cancer Chemother Pharmacol. 2011.
PMID: 21305290
Clinical Trial.
Two dose-limiting toxicities occurred at 225 mg/m(2), a transient ischemic attack and grade 3 transaminitis, thus ending dose escalation. Pharmacokinetic data indicated dose-related increases in C (max) and AUC values, although substantial inter-subject variability was obs …
Two dose-limiting toxicities occurred at 225 mg/m(2), a transient ischemic attack and grade 3 transaminitis, thus ending dose escalation. Ph …
Item in Clipboard
Cite
Cite